Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 465-473

  Gupta, Soumi ^a,d   Leutenegger, Christian M ^a   Dean, Gregg A ^b   Steckbeck, Jonathan D ^c   Cole, Kelly Stefano ^c   Sparger, Ellen E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MONOGRAM BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; LIVE VACCINE; PLASMID DNA; VIRUS ANTIBODY; VIRUS DNA; VIRUS VACCINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CAT; CAT DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; GENE DELETION; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; RETROVIRUS INFECTION; T LYMPHOCYTE ACTIVATION; VACCINATION; VIF GENE; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON TYPE II; PROVIRUSES; T-LYMPHOCYTES; VACCINATION; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL VACCINES;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS;

EID: 33846103469     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00815-06     Document Type: Article

References (38)

1. Barlough, J. E., C. D. Ackley, J. W. George, N. Levy, R. Acevedo, P. F. Moore, B. A. Rideout, M. D. Cooper, and N. C. Pedersen. 1991. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. Acquir. Immune Defic. Syndr. 4:219-227.
2. Barouch, D. H., and M. L. Letvin. 2000. DNA vaccination for HIV-1 and SIV. Intervirology 43:282-287.
3. Barouch, D. H., N. L. Letvin, and R. A. Seder. 2004. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol. Rev. 202:266-274.
4. Barouch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T.-M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, K. Beaudry, M. A. Lifton, C. E. Nickerson, W. L. Trigona, K. Punt, D. C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M.-E. Davies, M. Chastain, T. B. Strom, R. S. Gelman, D. C. Montefiori, M. G. Lewis, E. A. Emini, J. W. Shiver, and N. L. Letvin. 2000. Control of viremia and prevention of clinical AIDS in rhesus macaques by cytokine-augmented DNA vaccination. Science 290:486-491.
5. + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168:562-568.
6. Bendinelli, M., M. Pistello, S. Lombari, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-112.
7. Berzofsky, J. A., J. D. Ahlers, J. Janik, J. Morris, S. Oh, M. Terabe, and I. M. Belyakov. 2004. Progress on new vaccine strategies against chronic viral infections. J. Clin. Investig. 114:450-462.
8. Biragyn, A., I. M. Belyakov, Y. H. Chow, D. S. Dimitrov, J. A. Berzofsky, and L. W. Kwak. 2002. DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood 100:1153-1159.
9. Burkhard, M. J., and G. A. Dean. 2003. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr. HIV Res. 1:15-29.
10. Calarota, S. A., and D. B. Weiner. 2004. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants. Immunol. Rev. 199:84-99.
11. Cole, K. S., J. L. Rowles, B. A. Jagerski, M. Murphey-Corb, T. Unangst, J. E. Clements, J. Robinson, M. S. Wyand, R. C. Desrosiers, and R. C. Montelaro. 1997. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71:5069-5079.
12. Desrosiers, R. C., J. D. Lifson, J. S. Gibbs, S. C. Czajak, A. Y. M. Howe, L. O. Arthur, and R. P. Johnson. 1998. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1431-1437.
13. 12a.Dunham, S., J. Bruce, S. MacKay, M. Golder, O. Jarrett, and J. Neil. 2004. Abstr. 7th Int. Feline Retrovir. Res. Symp., abstr. Va 1.2. Polo Didattico G. Carmignani, Pisa, Italy.
14. Dunham, S. T., J. N. Flynn, M. A. Rigby, J. MacDonald, J. Bruce, C. Cannon, M. C. Golder, L. Hanlon, D. A. Harbour, N. A. Mackay, N. Spibey, O. Jarrett, and J. C. Neil. 2002. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Vaccine 20:1483-1496.
15. Egan, M. A., W. A. Charini, M. J. Kuroda, J. E. Schmitz, P. Racz, K. Tenner-Racz, K. Manson, M. Wyand, M. A. Lifton, C. E. Nickerson, T. Fu, J. W. Shiver, and N. L. Letvin. 2000. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. J. Virol. 74:7485-7495.
16. Enose, Y., M. Kita, T. Yamamoto, H. Suzuki, A. Miyake, R. Horiuchi, K. Ibuki, K. Kaneyasu, T. Kuwata, E. Takahashi, K. Sakai, K. Shinohara, T. Miura, and M. Hayami. 2004. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination. Arch. Virol. 149:1705-1720.
17. Gemeniano, M. C., E. T. Sawai, C. M. Leutenegger, and E. E. Sparger. 2003. Feline immunodeficiency virus Orf-A is required for virus particle formation and virus infectivity. J. Virol. 77:8819-8830.
18. Giavedoni, L. D., and T. Yilma. 1996. Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J. Virol. 70:2247-2251.
19. Giri, M., K. E. Ugen, and D. B. Weiner. 2004. DNA vaccines against human immunodeficiency virus type 1 in the past decade. Clin. Microbiol. Rev. 17:370-389.
20. Gorelick, R. J., R. E. Benveniste, J. D. Lifson, J. L. Yovandich, W. R. Morton, L. Kuller, B. M. Flynn, B. A. Fisher, J. L. Rossio, M. Piatak, Jr., J. W. Bess, Jr., L. E. Henderson, and L. O. Arthur. 2000. Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost. J. Virol. 74:11935-11949.
21. Gundlach, B. R., H. Linhart, U. Dittmer, S. Sopper, S. Reiprich, D. Fuchs, B. Fleckenstein, G. Hunsmann, C. Stahl-Hennig, and K. Überla. 1997. Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J. Virol. 71:2225-2232.
22. Gupta, S., C. Leutenegger, G. Dean, and E. Sparger. 2006. Construction and characterization of feline immunodeficiency proviral mutants that co-express interferon gamma and green fluorescent protein. AIDS Res. Hum. Retrovir. 22:342-349.
23. Horiuchi, R., W. Akahata, T. Kuwata, Y. Enose, E. Ido, H. Suzuki, A. Miyake, N. Saito, K. Ibuki, T. Goto, T. Miura, and M. Hayami. 2006. DNA vaccination of macaques by a full-genome SHIV plasmid that has an IL-2 gene and produces non-infectious virus particles. Vaccine 24:3677-3685.
24. Hosie, M. J., J. N. Flynn, M. A. Rigby, C. Cannon, T. Dunsford, N. A. Mackay, D. Argyle, B. J. Willett, T. Miyazawa, D. E. Onions, O. Jarrett, and J. C. Neil. 1998. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J. Virol. 72:7310-7319.
25. Letvin, N. L. 2005. Progress toward an HIV vaccine. Annu. Rev. Med. 56:213-223.
26. Lockridge, K., M. Chien, P. A. Luciw, and E. E. Sparger. 2000. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology 273:67-79.
27. Lockridge, K., S. Himathongkham, E. T. Sawai, M. Chien, and E. E. Sparger. 1999. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology 261:25-30.
28. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, P. Isola, A. Merico, L. Zaccaro, A. Rizzuti, and M. Bendinelli. 1999. AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus. Vaccine 18:119-130.
29. McCormick, A. L., M. S. Thomas, and A. W. Heath. 2001. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120. J. Infect. Dis. 184:1423-1430.
30. Muthumani, K., M. Bagarazzi, D. Conway, D. S. Hwang, K. Manson, R. Ciccarelli, Z. Israel, D. C. Montefiori, K. Ugen, N. Miller, J. Kim, J. Boyer, and D. B. Weiner. 2003. A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduces viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques. Vaccine 21:629-637.
31. Nimal, S., A. L. McCormick, M. S. Thomas, and A. W. Heath. 2005. An Interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming. Vaccine 23:3984-3990.
32. Pedersen, N. C., C. M. Leutenegger, J. C. Woo, and J. Higgins. 2001. Virulence differences between two field isolates in feline immunodeficiency virus (FIV-APetaluma and FIV-CpGammar) in young adult specific pathogen free cats. Vet. Immunol. Immunopathol. 79:53-67.
33. Rossio, J. L., M. T. Esser, K. Suryanarayana, D. K. Schneider, J. W. Bess, G. M. Vasquez, T. A. Wiltrout, E. Chertova, M. K. Grimes, Q. Sattentau, L. O. Arthur, L. E. Henderson, and A. R. Lifson. 1998. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72:7992-8001.
34. Sawai, E. T., M. S. Hamza, M. Ye, K. E. S. Shaw, and P. A. Luciw. 2000. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef. J. Virol. 74:2038-2045.
35. Singh, D. K., Z. Liu, D. Sheffer, G. A. Mackay, M. Smith, S. Dhillon, R. Hegde, F. Jia, I. Adany, and O. Narayan. 2005. A noninfectious simian/ human immunodeficiency virus DNA vaccine that protects macaques against AIDS. J. Virol. 79:3419-3428.
36. Sparger, E. E., A. M. Beebe, N. Dua, J. Elder, S. Himathongkam, M. Torten, and J. Higgins. 1994. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology 205:546-553.
37. Stahl-Hennig, C., B. R. Gundlach, U. Dittmer, P. Haaft, J. Heeney, W. Zou, D. Emilie, S. Sopper, and K. Uberla. 2003. Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 and interferon-γ. Virology 305:473-485.
38. Wang, S.-W., P. A. Kozlowski, G. Schmelz, K. Manson, M. S. Wyand, R. Glickman, D. Montefiori, J. D. Lifson, R. P. Johnson, M. R. Neutra, and A. Aldovini. 2000. Effective induction of simian immunodeficncy virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions. J. Virol. 74:10514-10522.